Dharminder Singh Chahal
Director/Board Member en MENDUS AB .
Fortuna: 537 424 $ al 31/03/2024
Origen de la red de primer grado Dharminder Singh Chahal.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Biotechnology | 33 | |
17
| Public Company | Biotechnology | 17 |
SkylineDx BV
 SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands.
8
| Holding Company | Medical/Nursing Services | 8 |
DCPrime BV
 DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Pan Cancer T
 Pan Cancer T BiotechnologyHealth Technology Pan Cancer T is a company based in Rotterdam, Netherlands that was founded in 2020 by Reno Debets, Dora Hammerl. The Dutch company focuses on advancing next generation TCR T cell therapies for hard-to-treat solid tumors. The company's approach includes exploiting unique targets for T cells that are exclusively and robustly expressed by multiple solid cancers and developing technologies that enhance the durability of the T cells. The company has ongoing R & D programs to develop safe and effective adoptive T cell therapies for patients with triple negative breast cancer as well as cancers of the bladder, ovarium, colorectum, prostate, skin, esophagus, lung, or brain. Rachel Abbott has been the CEO of the company since 2023.
5
| Holding Company | Biotechnology | 5 |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Swanbridge Capital Management BV
 Swanbridge Capital Management BV Investment ManagersFinance Swanbridge Capital Management is a venture capital firm, headquartered in Netherland. The frim founded in 2016 by Van Herk Investments, the Erasmus Medical Center and the City of Rotterdam.
4
| Private Company | Investment Managers | 4 |
VitalneXt BV
 VitalneXt BV Pharmaceuticals: GenericHealth Technology VitalneXt BV develops retails and manufactures products for healthy ageing. Its products include promanna, vital01 and other products. The firm develops products with evidence-based health benefits for the ageing population. It also develops new, proprietary, technologies, ingredients and products through its own network and through collaborations with the company's research partners. The company was founded by Rein Strijker in May 2013 and is headquartered in Amersfoort, the Netherlands.
4
| Holding Company | Pharmaceuticals: Generic | 4 |
Sensara BV
 Sensara BV Internet Software/ServicesTechnology Services Sensara BV engages in the development of self-learning, intelligent home monitoring solutions for the home care industry. It offers a smart sensor system, which detects unusual situations and sounds an alarm when something is wrong. The company was founded by Irek Karkowski and Ted Punt and is headquartered in Rotterdam, the Netherlands.
3
| Holding Company | Internet Software/Services | 3 |
Ceradis BV
 Ceradis BV Chemicals: AgriculturalProcess Industries Ceradis BV develops and markets environmental solutions for plant nutrition, crop protection, and formulation services. It focuses on the use of biological formulation additives and the development of biofungicides based on macro-organisms or natural products. The company was founded by Wim M. van der Krieken in 2005 and is headquartered in Wageningen, the Netherlands.
3
| Holding Company | Chemicals: Agricultural | 3 |
Medis Medical Imaging Systems BV
 Medis Medical Imaging Systems BV Packaged SoftwareTechnology Services Medis Medical Imaging Systems BV engages in the development and supply of software solutions for data imaging used by medical industry. Its products include Media Suite MR, Media Suite XA, Medis Suite CT, and Intravascular. The company was founded by Johan Hans C. Reiber in 1989 and is headquartered in Leiden, the Netherlands.
3
| Subsidiary | Packaged Software | 3 |
Sairopa B V
 Sairopa B V MiscellaneousMiscellaneous Sairopa B V is a Dutch company that develops medicines and operates as an investment holding company.
3
| Private Company | Miscellaneous | 3 |
Van Herk Investments BV
 Van Herk Investments BV Investment ManagersFinance Van Herk Investments BV (VHI) is the private equity investment arm of the Van Herk Groep BV, based in Rotterdam. The parent firm was established in the 1950s as a family business with a focus on real estate investments. VHI invests in listed and unlisted firms across diverse sectors primarily in The Netherlands.
2
| Subsidiary | Investment Managers | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Dharminder Singh Chahal a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC. | Biotechnology | Director/Board Member Director/Board Member | |
BioPhausia AB
 BioPhausia AB Medical DistributorsDistribution Services BioPhausia AB operates as a pharmaceutical company. It markets and distributes original drugs, generic products, and the parallel-imported medicines. The company is headquartered in Stockholm, Sweden. | Medical Distributors | Chairman | |
| ACTIVE BIOTECH AB | Biotechnology | Chief Executive Officer Public Communications Contact Chief Executive Officer | |
| MEDIVIR AB | Pharmaceuticals: Major | Chairman Chief Executive Officer Chief Executive Officer Director/Board Member Director of Finance/CFO | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree | |
Organon NV
 Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Synvolux Therapeutics BV
 Synvolux Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Synvolux Therapeutics BV provides drug delivery services. It is specialized in transporting of DNA, RNA (siRNA and RNAi) and proteins to the target destination. The company was founded in 2002 and is headquartered in Leiden, the Netherlands. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| McGill University | College/University | Graduate Degree Doctorate Degree | |
| PHARMING GROUP N.V. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| CELLAVISION AB | Medical Specialties | Director/Board Member | |
| BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Michigan | College/University | Masters Business Admin | |
| Stockholm School of Economics | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Masters Business Admin | |
| University of Uppsala | College/University | Doctorate Degree Graduate Degree | |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Chief Executive Officer Director/Board Member Director/Board Member Corporate Officer/Principal Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Executive Officer Director/Board Member | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of Amsterdam | College/University | Doctorate Degree Graduate Degree | |
Envirotainer AB
 Envirotainer AB Containers/PackagingProcess Industries Envirotainer AB provides cold chain solutions for the pharmaceutical supply chain. It offers active cold chain services, qualification services, shipment set up services, technical support, post-shipment analysis and telemetry solution. The company was founded in 1985 and is headquartered in Sollentuna, Sweden. | Containers/Packaging | Chief Executive Officer | |
| University of Lund | College/University | Director/Board Member Undergraduate Degree Masters Business Admin Doctorate Degree Undergraduate Degree | |
| Erasmus University Rotterdam | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| University of Leiden | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of Groningen | College/University | Doctorate Degree Graduate Degree | |
| Vrije Universiteit Amsterdam | College/University | Undergraduate Degree Doctorate Degree | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree | |
Van Herk Groep BV
 Van Herk Groep BV Financial ConglomeratesFinance Van Herk Groep BV provides investment services to the real estate, energy, and life science sectors. The company was founded by Aat van Herk and is headquartered in Rotterdam, the Netherlands. | Financial Conglomerates | Founder Director of Finance/CFO | |
| VIVESTO AB | Pharmaceuticals: Generic | Chief Executive Officer Director/Board Member | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| University of Gothenburg | College/University | Undergraduate Degree | |
ORCA Therapeutics BV
 ORCA Therapeutics BV Pharmaceuticals: GenericHealth Technology ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
InteRNA Technologies BV
 InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
Stockholm Chamber of Commerce
 Stockholm Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Stockholm Chamber of Commerce is a member of Swedish Chambers International, which is an umbrella organization for Swedish Chambers of Commerce abroad. The Chamber of Commerce in Stockholm provides contact information for those who are unsure of who to contact regarding their matter. The non-profit company is based in Stockholm, Sweden, and has subsidiaries in Sweden. The purpose of SCI is to strengthen the brand internationally, facilitate business for companies, and exchange experiences. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Qbtech AB
 Qbtech AB Information Technology ServicesTechnology Services Qbtech AB is a company that specializes in ADHD and related conditions. The company is based in Stockholm, Sweden and was founded in 2002. The Swedish company is backed by over 35 pieces of research and offer clinical research related to their products. The CEO is Carl Reuterskiöld. | Information Technology Services | Chief Executive Officer | |
| Universidad del Rosario | College/University | Doctorate Degree | |
Mellon Medical BV
 Mellon Medical BV Medical SpecialtiesHealth Technology Mellon Medical BV manufactures and develops surgical suturing devices. The firm’s suturing device, the Switch, is designed for surgeons who perform the challenging operations and can easily be rotated in the hand because of its pencil-like shape. The company was founded in April 2013 by Mark Vrancken Peeters and is headquartered in Nijmegen, the Netherlands. | Medical Specialties | Director/Board Member Chairman | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Nutrileads BV
 Nutrileads BV Food: Major DiversifiedConsumer Non-Durables Nutrileads BV develops food ingredi?nts with a specific nutritional value. It identifies promising lead ingredients, develops sustainable and commercially viable production processes and initiates scientific and clinical programs to test the health effects. The company was founded in 2012 by Erik Dam and Ruud Albers and is headquartered in Wageningen, the Netherlands. | Food: Major Diversified | Director/Board Member Chairman | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Synerkine Pharma BV
 Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Synerkine Pharma BV focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company was founded by Hans Preusting in 2018 and is headquartered in Utrecht, Netherlands. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| ELICERA THERAPEUTICS AB | Biotechnology | Director/Board Member General Counsel | |
Aduro Biotech Holdings Europe BV
 Aduro Biotech Holdings Europe BV BiotechnologyHealth Technology Aduro Biotech Holdings Europe BV operates as a biopharmaceutical company specializing in immune oncology antibody discovery. The firm’s technology creates a pipeline of antibodies aiming to treat the immune system of cancer patients. Its antibody portfolio includes immune checkpoint inhibitors and novel antibody formats. The company was founded by Wiebe Olijve, Andrea van Elsas, and Hans van Eenennaam in 2011 and is headquartered in Oss, the Netherlands. | Biotechnology | Founder Founder | |
| Actinova AB | Director/Board Member |
Estadísticas
Internacional
| Suecia | 19 |
| Países Bajos | 19 |
| Estados Unidos | 5 |
| Canadá | 3 |
| Reino Unido | 3 |
Sectorial
| Health Technology | 22 |
| Consumer Services | 17 |
| Commercial Services | 6 |
| Distribution Services | 2 |
| Health Services | 2 |
Operativa
| Director/Board Member | 294 |
| Corporate Officer/Principal | 121 |
| Chairman | 84 |
| Chief Executive Officer | 77 |
| Independent Dir/Board Member | 69 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Jane M. Birgitta Stymne Göransson | 50 |
| Jan Hendrik Egberts | 33 |
| Alf Gunnar Martin Nicklasson | 31 |
| Nanna Liebach Lüneborg | 29 |
| Sven Arne Andréasson | 24 |
| Thomas O. Hecht | 24 |
| Bernd Seizinger | 23 |
| Leonard Kruimer | 22 |
| Vincent Ossipow | 22 |
| Sven Rohmann | 20 |
| Jonas Jendi | 17 |
| Michel Briejer | 17 |
| Andrea van Elsas | 16 |
| Ulla Cristina Glad | 15 |
| Erik Esveld | 15 |
- Bolsa de valores
- Insiders
- Dharminder Singh Chahal
- Conexiones Empresas
